Medicamen Biotech Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 329.228 million compared to INR 357.856 million a year ago. Net income was INR 30.147 million compared to INR 36.784 million a year ago. Basic earnings per share from continuing operations was INR 2.47 compared to INR 3.05 a year ago. For the nine months, total revenue was INR 916.941 million. Net income was INR 84.825 million compared to INR 107.978 million a year ago. Basic earnings per share from continuing operations was INR 6.94 compared to INR 8.94 a year ago.